Friday 19 August 2016

NICE set to remove two drugs from the Cancer Drugs Fund

NICE set to remove two drugs from the Cancer Drugs Fund Everolimus for breast cancer and ibrutinib for mantle cell lymphoma are not cost-effective, NICE says. OnMedica

No comments:

Post a Comment